Myeloproliferative neoplasm with eosinophilia and T-lymphoblastic lymphoma with ETV6-LYN gene fusion

Blood Cancer J. 2016 Apr 8;6(4):e412. doi: 10.1038/bcj.2016.11.

Authors

N Telford¹, S Alexander², O J McGinn², M Williams³, K M Wood⁴, A Bloor⁵, V Saha^{2

6}

Affiliations

¹ Oncology Cytogenetics, The Christie Pathology Partnership, The Christie NHS Foundation Trust, Manchester, UK.
² Children's Cancer Group, Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer, University of Manchester, Manchester, UK.
³ Leukaemia Biology Group, Institute of Cancer, University of Manchester, Manchester, UK.
⁴ Department of Cellular Pathology, Royal Victoria Infirmary, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
⁵ Haematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, UK.
⁶ Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Disease Progression
ETS Translocation Variant 6 Protein
Eosinophilia / complications*
Eosinophilia / diagnosis
Eosinophilia / genetics*
Fatal Outcome
Humans
Male
Middle Aged
Myeloproliferative Disorders / complications*
Myeloproliferative Disorders / diagnosis
Myeloproliferative Disorders / drug therapy
Myeloproliferative Disorders / genetics*
Oncogene Proteins, Fusion / genetics*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / complications*
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
Proto-Oncogene Proteins c-ets / genetics*
Repressor Proteins / genetics*
src-Family Kinases / genetics*

Substances

Oncogene Proteins, Fusion
Proto-Oncogene Proteins c-ets
Repressor Proteins
lyn protein-tyrosine kinase
src-Family Kinases

Grants and funding